Stocktwits on MSN
Summit teams up with Daiichi Sankyo, AstraZeneca for cancer therapy trial – CEO calls it an 'important expansion'
Datroway cancer therapy has been commercialized by AstraZeneca and Daiichi Sankyo. ・There are currently 16 Phase 3 studies ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...
The NHS has shared information about the certain types of coughs that could mean you're suffering from lung cancer. The ...
Lung cancer screening eligibility increased markedly from 2018–2023 under USPSTF criteria, reflecting aging and substantial ...
Lung cancer remains the deadliest malignancy on the planet, and a sweeping new analysis of twenty years of scientific ...
The inherited mutation substantially increases the chance of developing lung cancer, including in people who don't smoke.
The award will support the development of a noninvasive approach to determine whether indeterminate pulmonary nodules are ...
Lung cancer incidence decreased 3.5%/year in males and 1.9%/year in females during 2018–2022, alongside a two-thirds increase ...
AI models accurately extracted smoking history to support lung cancer screening decisions. Read more about the findings.
SAN ANTONIO, September 30, 2026--bioAffinity and AvMEDICAL jointly presented CyPath Lung for the first time under their new distribution agreement at NAVREF 2026 Annual Conference.
Cancer death rates in the United States continued to fall for both men and women between 2019 and 2023. According to the 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results